Skip to Main Content

Paper Details

Evidence-based rationale for low dose nivolumab in critically ill patients with sepsis-induced immunosuppression.
Clin Transl Sci
2
2023
Author NameAffiliation
Peter PickkersDepartment of Intensive Care and Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen Medical Centre
  • 1 - 1

Datasets

Release 1.2